Phase 4
Completed N=442
Supervised Asthma Medication in Schools (SAMS)
Source: ClinicalTrials.gov NCT01997463 ↗Enrolled (actual)
442
Serious AEs
0.0%
Results posted
Mar 2022
Primary outcomePrimary: The Primary Outcome Will be the Score on the Juniper Asthma Control Questionnaire (ACQ) — 54; 70; 74; 95 Participants
◆ Published Evidence
Emerging
2citations · ~0 / year
School-supervised use of a once-daily inhaled corticosteroid regimen: A cluster randomized trial.
Summary
The investigators hypothesize that school-based, direct supervision of daily controller therapy will result in more effective asthma control, as assessed by the Asthma Control Questionnaire than usual care. Additionally, as the result of enhanced asthma control and resulting decrease in health care utilization, school-based, direct supervision of daily controller therapy will result in lower cost per quality-adjusted life year (QALY) gained than usual care.
Linked Publications
-
School-supervised use of a once-daily inhaled corticosteroid regimen: A cluster randomized trial.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Primary Outcome Will be the Score on the Juniper Asthma Control Questionnaire (ACQ) |
54; 70; 74; 95; 64; 85 | — |
Eligibility Criteria
Inclusion Criteria
- A child with asthma attending a Tucson Unified School District elementary school selected for the study.
Exclusion Criteria
- No asthma.
- Not attending a Tucson Unified School District elementary school selected for the study.
Data sourced from ClinicalTrials.gov (NCT01997463) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.